key: cord-0848570-ti61tc8b
authors: Brasil, Sérgio; Renck, Alessandra Covallero; Taccone, Fabio Silvio; Fontoura Solla, Davi Jorge; Tomazini, Bruno Martins; Wayhs, Sâmia Yasin; Fonseca, Sérgio; Bassi, Estevão; Lucena, Bruno; De Carvalho Nogueira, Ricardo; Paiva, Wellingson; Teixeira, Manoel Jacobsen; Frade Costa, Elaine Maria; Sá Malbouisson, Luiz Marcelo
title: Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID‐19
date: 2021-05-27
journal: Obes Sci Pract
DOI: 10.1002/osp4.534
sha: 985927d3d162a0d294e8326a96663b95f7a81613
doc_id: 848570
cord_uid: ti61tc8b

OBJECTIVE: Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID‐19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID‐19 among obese patients becomes suitable. METHODS: 50 cases of SARS by COVID‐19 were evaluated, for the presence of ICCI and cerebrovascular circulatory disturbances in correspondence with whether unfavorable outcomes (death or impossibility for mechanical ventilation weaning [MVW]) within 7 days after evaluation. The objective was to observe whether obese patients (BMI ≥ 30) disclosed worse outcomes and tests results compared with lean subjects with same clinical background. RESULTS: 23 (46%) patients among 50 had obesity. ICCI was verified in 18 (78%) obese, whereas in 13 (48%) of 27 non‐obese (p = 0,029). CHD were not significantly different between groups, despite being high prevalent in both. 69% unfavorable outcomes were observed among obese and 44% for lean subjects (p = 0,075). CONCLUSION: In the present study, intracranial compliance impairment was significantly more observed among obese subjects and may have contributed for SARS COVID‐19 worsen prognosis.

The association between obesity (body mass index > 30kg/m 2 ) and intracranial hypertension (ICH) has been widely described. [1] [2] [3] Elevation in the intracranial pressure (ICP) may reduce intracranial compliance (ICC) , what is the equilibrium among intracranial content (brain, blood volume and cerebrospinal fluid), 4 impacting cerebral perfusion and cellular metabolism. 5 Several mechanisms linking obesity with chronic ICH have been proposed, mainly as disturbances of cerebrospinal fluid circulation, 6, 7 dysregulation of the metabolic neuroendocrine axis, 8 compression of thoracic and abdominal organs impairing cerebral venous return, 9 sleep apnea leading to cerebral hemodynamics disorders (CHD) 6,10,11 and brain temperature elevation. 12 Additionally to genetic and epigenetic determinants, 13 these factors may also play a role in increasing risks of neurodegenerative diseases (NDD) development in this population.

ICH prevalence among general population has been not widely studied to the date, especially because techniques to assess ICP require skull opening for catheter introduction, what is ethically not recommended. Nevertheless, 90-95% of patients with idiopathic intracranial hypertension (IIH) symptoms have obesity. 14 Hence, the hypothesis of obesity coexisting with a lifetime regimen of ICH and consequently ICC impairment (ICCI) if obesity is untreated 15 becomes suitable.

At the current COVID-19 pandemic, obesity has been considered a prognostic risk factor, with particular monitoring and earlier respiratory support recommended for these patients. [16] [17] [18] Considering this background explained above, for obese patients with COVID-19 severe respiratory syndromes, the hypothesis of ICCI and CHDbeing higher when compared with lean patients is feasible. The objective of the present study was to evaluate the prevalence of ICCI and CHD in correlation with short-term clinical outcomes as death and mechanical ventilation weaning (MVW) in severe COVID-19 among patients with and without obesity.

A single center, observational and prospective study in six intensive care units (ICUs) of Hospital das Clínicas, São Paulo University, Brazil, from May to June 2020 was conducted. All methods were performed in accordance with the relevant guidelines and regulations, informed consent was obtained from all legally authorized representatives (LAR)/next of kin instead of the patients because of illness severity.

The study included consecutive COVID-19 severely ill patients for the observation of ICCI and CHD in this population although the observation of high prevalence of obesity among the included patients motivated this present analysis. All patients included had confirmed COVID-19 by real-time reverse transcription-polymerase chain reaction positive testing and were included within the first 72 h since the initiation of invasive mechanical ventilation. Exclusion criteria included the absence of LAR consent, the absence of temporal acoustic window for TCD assessment, patients unable to undergo ICC monitoring due to lesions and/or skin infections in the sensor application region and patients with head circumference smaller than 47 cm. The study protocol was according to the Standards for Reporting of Diagnostic Accuracy Studies (STARD) statement (Supplemental Table) .

Eligible subjects were identified by the ICU teams (SYW, SF, BT, EB and LMSM). As patients were included consecutively, inclusion of patients with and without obesity was spontaneous. Two assessments of CVH and ICC were performed: the first during the first 3 days from intubation and the second up to 72 h after extubation or tracheotomy without administration of sedatives; for patients who died while intubated only the first evaluation was considered. Clinical parameters, such as systemic arterial pressure, fluid balance, use of sedatives, PaO 2 and PaCO 2 , hemoglobin and body temperature, were concomitantly recorded. One operator, without knowledge of the individual clinical features, performed all evaluations. Data on demographic characteristics, Simplified Acute Physiologic Score (SAPS) 3, use of intravenous sedatives, vasopressors and other physiological and laboratory data were also collected.

ICC was evaluated non-invasively by assessing cranial deformation using a specific device (B4C; Brain4care Corp., São Carlos). The B4C sensor consists of a support for a sensor bar that detects local cranial bone deformations using specific sensors. The detection of these deformations is obtained by a cantilever bar modeled through finite element calculations. Voltage meters are attached to this bar for deformation detection. Non-invasive contact with the skull is obtained by adequate pressure directly into the scalp by means of a pin.

The system is positioned in the frontotemporal region, around 3 centimeters over the first third of the orbitomeatal line; consequently, avoiding temporal superficial artery main branches and temporal muscle, providing contact of the sensor with an area of thin skin and skull, whereas slight pressure is applied to the adjustable band until optimal signal is detected.

Variations in ICP cause deformations in the cranial bone, which are detected by the sensor bar. The device filters, amplifies and scans the sensor signal and sends the data to a mobile device. The method is completely non-invasive and painless. In addition, it does not interfere with any routine monitoring. The waveform obtained is equivalent to ICP waveform obtained using invasive techniques, such intraparenchymal probes or external ventricular derivation, 19 and the relation between its different components provides information on ICC. 20 In particular, each cardiac beat corresponds to an ICP waveform composed of three peaks: arterial pulsation (P1); cerebral venous flow, which is secondary to cyclic fluctuations of arterial blood volume, reflecting intracranial compliance (P2); the aortic valve closure (P3; Figure 1 ). 21 The B4C analytics system verified all data collected by the sensor, that is, ICP pulse waves morphology parameters such as the P2/P1 ratio. For this study, all calculations were performed using the mean pulse of the ICP, calculated by identifying and extracting all ICP pulses, excluding possible artifacts. The mean pulse was used to calculate the amplitudes of the P1 and P2 peaks, which were obtained by detecting the highest point of these peaks and subtracting the base value of the ICP pulse. The P2/P1 ratio was calculated by dividing the amplitude of these two points. In case of P2 > P1, ICC was defined as "abnormal". 

As a wide range of variables are involved in the prognosis of COVID-19, 26-29 our analyses were limited to the prevalence and predictive values of ICC and CVH disturbances on early unfavorable outcome (UO); between patients included consecutively and distributed in two groups according to presence or absence of obesity. UO was a composite endpoint including either absence of weaning from mechanical ventilation (MV) or death on day 7 after inclusion in the study.

CHD and ICC impairment were identified using the different combination of TCD and B4C values; in particular, P2/P1 ratio, mCBFV, eICP, PI and eCPP were categorized and an arbitrary score was developed to describe different degrees of these alterations (Table 1) . For each variable, severity was defined by a CHD/ICCI score from 1 to 4. As such, the sum of the severity score for each variable gave a score ranging from a minimum of 5 to a maximum of 20. The score was then classified as: "normal", that is, five points, which suggested no abnormalities; "mild CHD/ICCI abnormalities", that is, Six to seven points, which was associated with minor disturbances in one or two variables; "moderate CVH/ICC abnormalities", that is, Eight to nine points; and "severe CHD/ICCI", that is, ≥ 10 points.

A pilot study was performed. Using the upper confidence interval for the population variance approach to the sample size calculation, a pilot sample size between 20 and 40 was chosen, corresponding to standardized effect sizes of 0.4 and 0.7 (for 90% power based on a standard sample size calculation). 30 Thus, considering the risk of early deaths and lack of second TCD and B4C assessment, 50 patients were enrolled to test our hypothesis. Overall group's features are described in Table 2 were associated with unsuccessful MVW/death (Table 5) . Moreover, older patients tended to have a higher risk of ICCI. Figure 2 depicts the estimated probability of an altered intracranial compliance according to obesity status and age after multivariable adjustment.

In the present study, ICCI was significantly more present among patients with obesity. CHD prevalence was not different between groups, probably because our entire sample was composed by SARS patients, included in early stages of respiratory function depression and mechanical ventilation support, when CHD is commonly observed. 31 Survival and mechanical ventilatory support successful weaning were also significantly higher among non-obese subjects.

Despite of our exploratory study design, prevalence of obesity (46%) in our sample was considerably higher than Brazilian overall population obesity rate (20.7%), 32 but similar to previous studies reported, which have noticed increased risk of hospitalization, severe disease and invasive mechanical ventilation in COVID-19. 18, 33, 34 Therefore, obesity was pointed as a clinical predictor for adverse outcomes. 33, 34 Physicians must be alert to these early indicators to identify critical patients. 18, 35, 36 In our cohort, both groups (lean and obese) were similar in disease severity, whereas ICCI was sensibly more present among obese than lean patients. CHD given by altered mCBFV and PI, as a reflex of compromised cerebral perfusion pressure was also correlated with ICCI. Therefore, it seems to be a chain between obesity and disturbances in intracranial compliance and cerebral circulation. Although unfavorable outcomes were more frequently seen in patients with T A B L E 1 Thresholds for P2/P1 ratio, mCBFV, PI, eICP and eCPP. Progressive points were in accordance with the worst results With reference to COVID-19 and the brain, plenty of findings have been described. [45] [46] [47] Central nervous thrombosis seems to have an increased relative risk. 45 Considering obesity and COVID-19, justifications for higher aggressive disease in this population rely on cardiovascular, hematologic, autonomic, endocrine, metabolic, immune and inflammatory mechanisms. 49 The amount of adipose tissue, rich in angiotensinconverting enzyme 2 (ACE2) receptors, the association between obesity and with type 2 diabetes which also leads to an increase in ACE2 receptors and an overactivation of the renin-angiotensinaldosterone system in adipose tissue result in difficult systemic hemodynamic control. 49 COVID-19 is clearly linked with coagulopathy, and in case of obesity higher risk of venous thromboembolism. 49 In obesity there is reduced macrophage activation, increased proinflammatory cytokine production, and impaired B and T cell activation. 50 The circuit obesity-ICH-COVID-19 may find its vertex in invasive mechanical ventilation. Ventilating obese patients is quite challenging due to decreased diaphragmatic excursion, decreased expiratory reserve volume, and decreased lung functional capacity. 50 Besides proper arterial pressure management, ventilation has a crucial role on the prevention of brain's secondary damages even when primary disease is not on the CNS, as sepsis per example, 51 however, adjustment of these parameters are not enough if neurovascular coupling has been lost. 52 The limitation of chest wall and respiratory system elastances are correlated to elevation in ICP when positiveend-expiratory-pressure is applied, 53 what is expected for our population with obesity and SARS. These observations may justify the higher prevalence of ICCI among obese subjects in our study.

Finally, pronation positioning, what was often applied for ventilation of COVID-19 severe patients, 54 normally takes patients off the ideal 30°of head elevation, for ideal CSF transit and venous return. 55 Perhaps the ideal positioning during pronation would be reverse Trendelenburg, although this was not verified in this study.

This study had several limitations to be acknowledged. Our findings showed association and not causality between UO and alterations in cerebral hemodynamics. Routine daily assessment of these variables as potential therapies to restore "normal" brain hemodynamics will be in this setting. Second, the correlation between the B4C system and other surrogate of brain compliance, such as invasive ICP monitoring, has not been validated yet. The thresholds applied in our study were, however, extrapolated from the previous knowledge on ICC and ICP research. As this system acquires intracranial information through an extracranial technique, precaution is needed. Third, we could not perform neurological imaging during the study period, which is a hindrance to elucidate the etiology of the alterations in intracranial pressure pulse waveform in COVID-19, whether as primary CNS injury or secondary to respiratory or other systemic complications. Forth, availability of operators to assess brain hemodynamics restricted the study exclusively for severe COVID-19 admitted to the ICU. Finally, we used a composite endpoint of early systemic dysfunction, which is not specific for brain damage; long-term neurological assessment should be evaluated in future studies in association with early disturbances of brain perfusion and compliance.

In the present study, intracranial compliance impairment was significantly more observed among obese subjects and may have contributed for SARS COVID-19 worsen prognosis. Further studies with wider samples are needed to determine ICCI prevalence in this population precisely.

We thank all Hospital das Clinicas ICU nurses and intensivists that have been engaged and absorbed by these complex patients, and yet they found a willingness to cooperate with the realization of this study. F I G U R E 2 Estimated probability of intracranial compliance impairment according to obesity status and age (adjusted for PaO2/ FiO2 and laboratory parameters after multiple imputation)

There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. 

Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity

Idiopathic intracranial hypertension in the British population with obesity

Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer healthcare system

Assessment of dynamic intracranial compliance in children with severe traumatic brain injury: proof-of-concept

Cerebral hemodynamics: concepts of clinical importance

Idiopathic intracranial hypertension: the monster within

Do most patients with a spontaneous cerebrospinal fluid leak have idiopathic intracranial hypertension?

Reviewing the recent developments in idiopathic intracranial hypertension

Total and compartmental chest wall volumes, lung function, and respiratory muscle strength in individuals with abdominal obesity: effects of body positions

Feasibility of unattended home sleep apnea testing in a cognitively impaired clinic population

Dynamic modeling of apnea induced concurrent variations in arterial blood pressure and cerebral blood flow velocity

Acute sleep deprivation elevates brain and body temperature in rats

Environment and gene association with obesity and their impact on neurodegenerative and neurodevelopmental diseases. Front Neurosci

Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions

Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses

Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and metaanalysis

Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: A large retrospective study from the Bronx

Covichem: A biochemical severity risk score of COVID-19 upon hospital admission

CabellaBCT,deOliveiraSM,deOliveiraRS. Prediction of intracranial hypertension through noninvasive intracranial pressure waveform analysis in pediatric hydrocephalus

Intracranial pressure wave morphological classification: automated analysis and clinical validation

Intracranial pressure monitoring: gold standard and recent innovations

Assessment of dynamic cerebral autoregulation based on spontaneous fluctuations in arterial blood pressure and intracranial pressure

Multimodal non-invasive assessment of intracranial hypertension: an observational study

Cerebral perfusion pressure in head-injured patients: A noninvasive assessment using transcranial Doppler ultrasonography

The accuracy of transcranial Doppler in excluding intracranial hypertension following acute brain injury: A multicenter prospective pilot study

Renin-angiotensin system blockers and susceptibility to COVID-19: A multinational open science cohort study

Age is just a number: A critically important number for COVID-19 case fatality

Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study

Covid-19 and the digestive system

On the use of the upper confidence limit for the variance from a pilot sample for sample size determination

Tidal volume lowering by instrumental dead space reduction in brain-injured ARDS patients: effects on respiratory mechanics, gas exchange, and cerebral hemodynamics

Prevalência e fatores associados da obesidade na população brasileira: estudo com dados aferidos da Pesquisa Nacional de Saúde

Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Effect of obesity and body mass index on coronavirus disease 2019 severity: a systematic review and meta-analysis

Obesity is associated with severe forms of COVID-19

European headache federation guideline on idiopathic intracranial hypertension

Idiopathic intracranial hypertension in pregnancy

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: The Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol

Clock genes, inflammation and the immune system-implications for diabetes, obesity and neurodegenerative diseases

High fat diet consumption results in mitochondrial dysfunction, oxidative stress, and oligodendrocyte loss in the central nervous system

Neural underpinnings of obesity: the role of oxidative stress and inflammation in the brain

Neck circumference and cerebral gray matter volume

Obesity and muscle may have synergic effect more than independent effects on brain volume in community-based elderly

Cerebral venous thrombosis and SARS-CoV-2 infection: A systematic review and meta-analysis

COVID-19: Neuroimaging features of a pandemic

Coronavirus disease 2019 and neurodegenerative disease: What will the future bring?

COVID-19 and neurological disorders: Are neurodegenerative or neuroimmunological diseases more vulnerable?

Obesity and outcomes in COVID-19: When an epidemic and pandemic collide

Obesity a predictor of outcomes of COVID-19 hospitalized patients-a systematic review and metaanalysis

Impaired cerebral autoregulation is associated with brain dysfunction in patients with sepsis

Cerebral autoregulation and neurovascular coupling are progressively impaired during septic shock: An experimental study

Intracranial pressure responsiveness to positive end-expiratory pressure is influenced by chest wall elastance: a physiological study in patients with aneurysmal subarachnoid hemorrhage

Ventilation of coronavirus disease 2019 patients

Current status and outlook for the management of intracranial hypertension after traumatic brain injury: decompressive craniectomy, therapeutic hypothermia, and barbiturates

Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19